Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Contributions to Nephrology|May 23, 2012
Daily hemodialysis improves uremia-associated clinical parameters in the short termEriko Kojima, Hitoshi Hoshi, Yusuke Watanabe, et al.Journal of Atherosclerosis and Thrombosis|December 9, 2008
Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseasesTsuneo Takenaka, Hitoshi Hoshi, Nobutaka Kato, et al.Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|September 21, 2006
Long-term follow-up of patients treated with a combination of continuous ambulatory peritoneal dialysis and hemodialysisHitoshi Hoshi, Hidetomo Nakamoto, Yoshihiko Kanno, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 25, 2011
Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseasesTsuneo Takenaka, Kosuke Uchida, Eriko Kojima, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 9, 2010
Seasonal variations of daily changes in blood pressure among hypertensive patients with end-stage renal diseasesTsuneo Takenaka, Eriko Kojima, Keita Sueyoshi, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 8, 2012
Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathyTsuneo Takenaka, Kanako Nobe, Mika Okayama, et al.Cardiology Research and Practice|November 30, 2010
Height constitutes an important predictor of mortality in end-stage renal diseaseTsuneo Takenaka, Takahiko Sato, Hitoshi Hoshi, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 17, 2009
Zigzagged augmentation index in diabetesTsuneo Takenaka, Takahiko Sato, Hitoshi Hoshi, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 29, 2013
Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy on hemodialysisTsuneo Takenaka, Mika Okayama, Eriko Kojima, et al.Pageof 1